1789 — AK Medical Holdings Balance Sheet
0.000.00%
- HK$7.05bn
- HK$5.58bn
- CNY1.48bn
Annual balance sheet for AK Medical Holdings, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 841 | 1,042 | 757 | 1,032 | 1,466 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 539 | 547 | 577 | 618 | 694 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 1,934 | 2,065 | 1,975 | 2,178 | 2,700 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 382 | 436 | 575 | 684 | 700 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 2,605 | 2,774 | 3,003 | 3,335 | 3,663 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 489 | 436 | 498 | 596 | 658 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 574 | 531 | 611 | 697 | 750 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| ESOP Debt Guarantee | |||||
| Other Equity | |||||
| Total Equity | 2,032 | 2,244 | 2,392 | 2,638 | 2,913 |
| Total Liabilities & Shareholders' Equity | 2,605 | 2,774 | 3,003 | 3,335 | 3,663 |
| Total Common Shares Outstanding |